Medicare Enrolled
Dr. Robert Cary, MD
Family Medicine · Longview, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cary? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cary
Dr. Robert Cary is a family medicine in Longview, TX, with 20 years in practice. Based on federal Medicare data, Dr. Cary performed 5,596 Medicare services across 3,796 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cary received a total of $13,998 from 59 pharmaceutical and/or device companies across 996 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cary is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 3% volume in TX$ $13,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,596
Medicare services
Top 3% in TX for family medicine
3,796
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~280 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 494 | $72 | $200 |
| Blood draw (venipuncture) | 456 | $8 | $20 |
| Comprehensive metabolic blood panel | 392 | $10 | $105 |
| Complete blood count (CBC) with differential | 384 | $8 | $40 |
| Office visit, established patient (20-29 min) | 366 | $55 | $135 |
| Lipid panel (cholesterol and triglycerides) | 345 | $13 | $66 |
| Urinalysis, manual | 305 | $3 | $20 |
| Hemoglobin A1c test (diabetes monitoring) | 272 | $9 | $60 |
| Thyroid stimulating hormone (TSH) test | 237 | $16 | $70 |
| Automated urinalysis | 228 | $2 | $18 |
| Annual wellness visit, follow-up | 211 | $124 | $130 |
| Creatine kinase (cardiac enzyme) level, total | 199 | $6 | $27 |
| Chronic care management, first 20 min/month | 167 | $41 | $65 |
| Urinalysis with microscopic exam | 132 | $3 | $22 |
| Vitamin D level test | 117 | $29 | $140 |
| Prostate cancer screening; prostate specific antigen test (psa) | 110 | $19 | $95 |
| Electrocardiogram (EKG), 12-lead | 106 | $9 | $65 |
| Drug injection, under skin or into muscle | 92 | $7 | $50 |
| Urine microalbumin test (kidney screening) | 87 | $6 | $70 |
| Creatinine test (kidney function) | 87 | $5 | $25 |
| Free thyroxine (T4) test | 70 | $9 | $41 |
| Urine culture, bacterial colony count | 66 | $8 | $35 |
| Injection, methylprednisolone acetate, 80 mg | 61 | $6 | $20 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 50 | $29 | $70 |
| Chronic care management, additional 20 min/month | 47 | $36 | $50 |
| Antibiotic sensitivity test | 46 | $8 | $40 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 46 | $80 | $150 |
| Basic metabolic blood panel | 35 | $8 | $59 |
| Transitional care management services for problem of at least moderate complexity | 34 | $154 | $300 |
| PSA test (prostate cancer screening) | 32 | $18 | $95 |
| Transitional care management services for problem of high complexity | 31 | $177 | $410 |
| Urine culture, bacterial identification | 29 | $8 | $20 |
| Flu vaccine administration | 26 | $30 | $31 |
| Screening mammography | 25 | $85 | $300 |
| 3D screening mammography (tomosynthesis) | 24 | $23 | $71 |
| Flu vaccine, high-dose | 23 | $72 | $85 |
| Natriuretic peptide (heart and blood vessel protein) level | 22 | $38 | $110 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 21 | $9 | $45 |
| Chest X-ray, 2 views | 19 | $21 | $76 |
| Vitamin B-12 level test | 18 | $15 | $77 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $40 | $80 |
| Complete ultrasound scan of abdomen | 16 | $45 | $235 |
| Joint injection, major joint | 15 | $51 | $240 |
| Bone density scan (DEXA) | 12 | $28 | $83 |
| Bacterial culture, aerobic | 12 | $8 | $50 |
| Low dose ct scan of chest for lung cancer screening | 11 | $87 | $271 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,998
Total received (2018-2024)
Avg $2,000/year across 7 years
Top 2% in TX for family medicine
59
Companies
996
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,921 (92.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,077 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$242
2023$2,400
2022$3,070
2021$2,041
2020$1,594
2019$2,152
2018$2,499
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,987
Novo Nordisk Inc
$1,469
AstraZeneca Pharmaceuticals LP
$1,229
GlaxoSmithKline, LLC.
$1,183
PFIZER INC.
$1,004
Boehringer Ingelheim Pharmaceuticals, Inc.
$775
Lilly USA, LLC
$683
AbbVie Inc.
$649
Janssen Pharmaceuticals, Inc
$420
Amarin Pharma Inc.
$343
Astellas Pharma US Inc
$285
Allergan Inc.
$279
Novartis Pharmaceuticals Corporation
$278
Merck Sharp & Dohme Corporation
$258
Takeda Pharmaceuticals U.S.A., Inc.
$244
Otsuka America Pharmaceutical, Inc.
$244
Merck Sharp & Dohme LLC
$215
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$190
Radius Health, Inc.
$187
ABBVIE INC.
$183
SANOFI-AVENTIS U.S. LLC
$183
Teva Pharmaceuticals USA, Inc.
$177
Bayer HealthCare Pharmaceuticals Inc.
$174
Allergan, Inc.
$160
Exact Sciences Corporation
$106
Biohaven Pharmaceutical Holding Company Ltd.
$100
Integra LifeSciences Corporation
$82
Kowa Pharmaceuticals America, Inc.
$80
Eisai Inc.
$70
Abbott Laboratories
$68
Daiichi Sankyo Inc.
$63
ITI, Inc.
$57
Dynavax Technologies Corporation
$53
IDORSIA PHARMACEUTICALS US INC
$50
Nevro Corp.
$38
Boston Scientific Corporation
$35
ARBOR PHARMACEUTICALS, INC.
$35
Biohaven Pharmaceuticals, Inc.
$32
Avanir Pharmaceuticals, Inc.
$26
Antares Pharma, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Xeris Pharmaceuticals, Inc.
$19
Tris Pharma Inc
$19
Jazz Pharmaceuticals Inc.
$18
Almatica Pharma LLC
$18
Orexigen Therapeutics, Inc.
$18
EISAI INC.
$15
Purdue Pharma L.P.
$15
Supernus Pharmaceuticals, Inc.
$14
Ironwood Pharmaceuticals, Inc
$14
GE HEALTHCARE
$14
Horizon Therapeutics plc
$14
Synergy Pharmaceuticals Inc
$13
Paratek Pharmaceuticals, Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
Shire North American Group Inc
$12
AbbVie, Inc.
$11
Inogen, Inc.
$6
Top 3 companies account for 33.5% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · AirDuo Digihaler · Amitiza · Androgel · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Belviq · CAPLYTA · CELEBREX · CHANTIX · CONTRAVE · CREON · Cologuard Collection Kit · DUZALLO · Dayvigo · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL9 · GRALISE · GVOKE PFS · Heplisav-B · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYDAYIS · Myrbetriq · NOCDURNA · NUEDEXTA · NURTEC ODT · NUZYRA · OFEV · OMNIGRAFT · Omnia · Otezla · Otovel · Ozempic · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · SYMPROIC · SYNJARDY · SYNVISC-ONE · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Tresiba · Tribenzor · Trintellix · Trudhesa · Trulance · Tymlos · UBRELVY · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · XYREM · Xultophy 100/3.6 · Xyrem
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Equivalent to $250 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
81
Per 100K population
64.9
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cary is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cary experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cary performed 494 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cary receive payments from pharmaceutical companies?
Yes. Dr. Cary received a total of $13,998 from 59 companies across 996 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cary's costs compare to other family medicines in Longview?
Dr. Cary's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Longview
Browse family medicines in Longview ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology